Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. scholar.google.com › citations‪John F Seymour‬ - ‪Google Scholar‬

    John F Seymour. Professor of Medicine, Director Dept of Haematology Peter MacCallum Cancer Centre & Royal Melbourne. Verified email at petermac.org - Homepage. Hematologic malignancies....

  2. www.nejm.org › doi › fullVenetoclax–Rituximab in Relapsed or Refractory Chronic ...

    21 de mar. de 2018 · Authors: John F. Seymour, M.B., B.S., Ph.D., Thomas J. Kipps, M.D., Barbara Eichhorst, M.D., Peter Hillmen, M.B., Ch.B., James D’Rozario, M.B., B.S., Sarit Assouline, M.D., Carolyn Owen, M.D...

    • John F. Seymour, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario, Sarit Assouline...
    • 2018

  3. en.wikipedia.org › wiki › John_Seymour_(CaliforniaJohn Seymour (California politician) - Wikipedia

    John Francis Seymour Jr. (born December 3, 1937) is an American retired politician who served as a United States senator from California from 1991 to 1992. A member of the Republican Party , he was appointed to continue Pete Wilson 's term but lost the special election to finish it to Democratic nominee and former San Francisco mayor ...

  4. ashpublications.org › blood › articleDegraders upgraded: the rise of PROTACs in hematological ...

    28 de mar. de 2024 · John F. Seymour. Blood (2024) 143 (13): 1218–1230. https://doi.org/10.1182/blood.2023022993. Article history. Share. Tools. Abstract. Targeted protein degradation (TPD) is a revolutionary approach to targeted therapy in hematological malignancies that potentially circumvents many constraints of existing small-molecule inhibitors.

  5. Imágenes

    • John F Seymour - Alchetron, The Free Social Encyclopedia
    • Photos de John Seymour - Babelio.com
    • [Police Chief John F. Seymour] — Calisphere
    • John Seymour (author) - Alchetron, The Free Social Encyclopedia
    • John Seymour (1474-1536) – kleio.org
    • John Seymour, cable-laying Master Mariner.

    Ver todo

  6. pubmed.ncbi.nlm.nih.gov › 34102145Should Undetectable Minimal Residual Disease Be the Goal of ...

    Authors. Othman Al-Sawaf 1 , John F Seymour 2 , Arnon P Kater 3 , Kirsten Fischer 1. Affiliations. 1 Department of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University Hospital, German CLL Study Group, Gleueler Strasse 176, 50935 Cologne, Germany.

    • Othman Al-Sawaf, John F. Seymour, Arnon P. Kater, Kirsten Fischer
    • 2021

  7. onlinelibrary.wiley.com › doi › 10Approach to relapsed CLL including Richter Transformation

    9 de jun. de 2023 · John F. Seymour. First published: 09 June 2023. https://doi.org/10.1002/hon.3146. Sections. PDF. Tools. This section will review the assessment and approved and generally available treatment options for patients with relapsed CLL, including the context of Richter Transformation (the development of diffuse large B-cell lymphoma). 1.

  8. onlinelibrary.wiley.com › doi › bookPrecision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic ...

    15 de mar. de 2023 · John F. Seymour MBBS Ph.D. heads the Department of Haematology of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital and is Professor of Medicine at the University of Melbourne. He completed a translational research fellowship at the MD Anderson Cancer Center in Houston, and has received their Distinguished Alumnus award.